Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA)

Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA)

• CAS Number: 199807-33-5
• UNSPSC Description: Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) (Cyclo(RGDfV) (TFA))is an integrin αvβ3 inhibitor. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) has antitumor activity. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) can be used for the research of acute myeloid leukemia[1].
• Target Antigen: Apoptosis; Integrin
• Type: Peptides
• Related Pathways: Apoptosis;Cytoskeleton
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/Cyclo_Arg-Gly-Asp-D-Phe-Val__TFA.html
• Purity: 99.77
• Solubility: 10 mM in DMSO|H2O : 2 mg/mL (ultrasonic;warming;adjust pH to 2-3 with HCl)
• Smiles: O=C([C@@H](NC(CNC([C@H](CCCNC(N)=N)NC([C@H](C(C)C)NC1=O)=O)=O)=O)CC(O)=O)N[C@@H]1CC2=CC=CC=C2.FC(C(O)=O)(F)F
• Molecular Weight: 688.65
• References & Citations: [1]Shen ZH, et al. Targeting of the leukemia microenvironment by c(RGDfV) overcomes the resistance to chemotherapy in acute myeloid leukemia in biomimetic polystyrene scaffolds. Oncol Lett. 2016 Nov;12(5):3278-3284.
• Shipping Conditions: Blue Ice
• Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
• Clinical Information: No Development Reported